Table 4.
Adiposity measures across 25(OH)D cut-offs as: sufficient (> 50 nmol/L), insufficient (30-50 nmol/L) and deficient (< 30 nmol/L)
| NG | ||||
|---|---|---|---|---|
| Factor | Sufficient (> 50 nmol/L) | Insufficient (30-50 nmol/L) | Deficient(< 30 nmol/L) | p-value |
| N | 46 | 69 | 76 | |
| Fat % | 14.7 (10.9, 19.9) | 21.6 (14.9, 32.5) | 27.4 (20.2, 36.5) | 0.0001 |
| Fat Mass | 4.5 (3.0, 7.7) | 8.3 (4.2, 17.4) | 13.8 (8.2, 23.6) | 0.0001 |
| BMI Percentile | 32.5 (5.0, 63.0) | 75.0 (16.0, 95.0) | 77.0 (28.0, 95.5) | 0.0003 |
| Impedance | 650.5 (590.2, 703.5) | 619.5 (553.8, 678.6) | 578.5 (519.0, 642.0) | 0.0101 |
| T1D | ||||
| N | 38 | 54 | 25 | |
| Fat % | 16.1 (11.9, 26.4) | 22.4 (15.1, 29.6) | 26.3 (16.6, 31.7) | 0.021 |
| Fat Mass | 6.0 (3.3, 11.6) | 10.4 (6.0, 15.9) | 13.6 (6.6, 18.8) | 0.005 |
| BMI Percentile | 41.5 (17.0, 69.0) | 71.5 (51.0, 88.0) | 76.0 (49.0, 92.0) | 0.007 |
| Impedance | 625.1 (583.2, 706.5) | 597.0 (533.1, 669.4) | 593.1 (544.8, 642.8) | 0.027 |
Comparison was carried out across 25(OH)D categories using Kruskal–Wallis test with Bonferroni adjustment. Total sample is restricted to number of patients undergoing bioelectrical impedance analysis. Median (IQR) are presented. NG normoglycaemic controls, T1D type 1 diabetes